← brief for 2026-09-09 · Slowing decline

GLP-1 Receptor Agonists and Muscle Loss in Chronic Kidney Disease.

Article No results yet Peer reviewed

Key takeaways

A published journal piece on GLP-1 drugs, the weight-loss and diabetes medicines, and muscle loss in people with chronic kidney disease. Losing muscle matters in kidney disease because it is linked to weakness and worse outcomes. No abstract or data came through with this record, so there is nothing here to grade. Treat it as a discussion of a real concern, not evidence about how large that concern is.

Who did this work

Sawaira F · Mahmood HA · Ameer MH · Abbas A · Ullah G · Hassan I · Ehsan N · T Ahmed NA

Source

Article · PubMed, the drug frontier · 2026 Sep 9
https://pubmed.ncbi.nlm.nih.gov/42711767/